ROS & Redox Probe Development Service
Reactive oxygen species (ROS) and redox status are central indicators of mitochondrial function, oxidative stress, inflammation, cell death, drug response, and disease progression. MitoGlowing™ provides a comprehensive ROS & Redox Probe Development Service to support custom fluorescent probe design, synthesis, photophysical characterization, selectivity testing, biological validation, and assay development for mitochondrial ROS imaging, redox biology, disease mechanism research, drug screening, and preclinical translational studies.
Introduction to ROS & Redox Probes
Reactive oxygen species, including hydrogen peroxide (H₂O₂), superoxide anion radical (O₂•⁻), hydroxyl radicals, peroxynitrite-related species, and downstream oxidants, play dual roles in biological systems. At controlled levels, ROS participate in redox signaling, metabolism regulation, immune response, and cell fate control. Under pathological or stress conditions, abnormal ROS accumulation can damage proteins, lipids, nucleic acids, and organelles, contributing to mitochondrial dysfunction, inflammation, apoptosis, ferroptosis, neurodegeneration, cancer progression, and cardiovascular injury.
Because mitochondria are major sources and targets of ROS, mitochondrial ROS probes are especially valuable for evaluating oxidative phosphorylation stress, electron transport chain dysfunction, metabolic imbalance, redox-sensitive signaling pathways, and therapeutic response. Different ROS species have different lifetimes, diffusion properties, reaction mechanisms, and biological meanings; therefore, probe development requires careful matching of the target analyte, recognition chemistry, localization strategy, fluorescence readout, and biological model.
ROS and redox probes can be designed as turn-on, ratiometric, dual-channel, near-infrared, two-photon, organelle-targeted, reversible, or high-throughput assay-compatible systems. Reliable ROS measurement also requires appropriate controls, selectivity testing, dose-response optimization, and careful interpretation because general ROS probes may respond to multiple oxidants or depend on biological context.
Fig.1 Diffusable ROS Probes (Total Cellular ROS Detection)
Features of ROS & Redox Probe Development
- Target-specific ROS and redox probe design for H₂O₂, superoxide, GSH/GSSG ratio, total ROS, mitochondrial ROS, oxidative stress indicators, and customized redox-responsive systems.
- Mitochondria-focused probe engineering with optimized mitochondrial localization, retention, membrane permeability, low cytotoxicity, and compatibility with mitochondrial function assays.
- Multiple fluorescence readout options including turn-on, ratiometric, dual-channel, NIR, two-photon, AIE-based, self-assembled, reversible, and high-content imaging-compatible probe formats.
- High selectivity and anti-interference testing against ROS/RNS/RSS, thiols, metal ions, pH, viscosity, serum components, drug autofluorescence, and biological matrix effects.
- Multi-platform detection compatibility for fluorescence microscopy, confocal imaging, two-photon imaging, flow cytometry, plate-reader assays, high-content screening, zebrafish imaging, and selected in vivo imaging workflows.
- Application-specific biological validation for cancer therapy evaluation, drug-induced toxicity, neurodegeneration, cardiovascular disease, inflammation, ischemia/reperfusion injury, nanomedicine evaluation, and redox biomarker studies.
Our Services
MitoGlowing™ provides an integrated ROS and redox probe development workflow covering probe strategy design, molecular synthesis, photophysical testing, redox-response characterization, biological validation, imaging assay development, and application-specific optimization.
H₂O₂ Probes Development Service
Custom probes for hydrogen peroxide detection, mitochondrial oxidative stress imaging, disease models, food safety testing, and drug toxicity evaluation.
O₂•⁻Superoxide Probes Development Service
Custom O₂•⁻ probes for mitochondrial dysfunction, neuroinflammation, inflammatory disease imaging, cancer microenvironment research, and antioxidant screening.
GSHGSSG
Glutathione (GSH/GSSG) Ratio Probes Development Service
Probe and assay workflows for glutathione redox status, antioxidant capacity, chemotherapy response, immune regulation, and high-throughput screening.
Supported Sample Types and Models
- Cancer cell lines, tumor spheroids, organoids, and tumor microenvironment models
- Drug-treated, stress-treated, hypoxia/reoxygenation-treated, ischemia/reperfusion-related, inflammatory stimulus-treated, or nanomaterial-treated cells
- Zebrafish embryos and selected small animal imaging models
- Neuronal and neurodegenerative disease models
- Immune and inflammatory models, including macrophages and neutrophils
- Hepatocytes, liver injury models, fatty liver models, and hepatotoxicity models
- Mitochondrial dysfunction and oxidative stress models
- Cardiomyocyte and cardiotoxicity models
- Plasma, serum, cell lysates, tissue extracts, tissue sections, and selected biological fluids
- 96-well and 384-well high-throughput assay formats and other customized models
Application
Cancer Theranostics and ROS-Activated Probe Imaging
ROS-responsive probes can be used to visualize oxidative stress in tumor tissues and support activatable cancer imaging or theranostic probe development. Hydromethidine-related probes have been evaluated for in vivo ROS imaging in brain models, where labeled hydromethidine was converted by superoxide or hydroxyl radicals and retained in ROS-producing regions after oxidative stimulation. This type of radical-trapping strategy supports the broader development of ROS-activated imaging probes for disease localization and therapy monitoring.
This application supports ROS-responsive probe development for tumor microenvironment imaging, ROS-triggered drug release, fluorescence-guided therapy evaluation, and visual monitoring of oxidative stress during anticancer treatment.
Drug Development and Anticancer Efficacy Evaluation
ROS detection is widely used in anticancer drug discovery because many chemotherapeutic drugs and investigational pro-oxidative compounds induce ROS directly or indirectly. Fluorescent ROS probes can help establish evaluation workflows linking drug-induced antioxidant-system disruption, ROS accumulation, and cancer cell death.
This application supports candidate drug screening, drug resistance studies, Nrf2/HO-1 pathway analysis, antioxidant system targeting, combination therapy evaluation, and non-target organ oxidative injury assessment.
Neurodegenerative Disease and ROS-Regulating Biomaterials
ROS probes are important tools for evaluating oxidative stress in neurodegenerative disease models and redox-regulating biomaterial therapies. In Alzheimer's disease, Parkinson's disease, neuroinflammation, and brain injury research, probes such as MitoSOX, DCFH-DA, two-photon ROS probes, and mitochondria-targeted redox probes can be used to assess oxidative stress changes and therapeutic response.
This application supports ROS probe development for neuroprotective drug screening, antioxidant nanozyme evaluation, disease progression monitoring, and mitochondrial oxidative stress analysis in brain-related models.
Cardiovascular and Cerebrovascular Disease Models
ROS dysregulation is closely related to cardiovascular and cerebrovascular injury, including atherosclerosis, myocardial infarction, ischemic stroke, vascular inflammation, and endothelial dysfunction. Fluorescent ROS probes can be combined with nanozyme, drug delivery, or antioxidant therapy systems to evaluate ROS modulation in vascular and cardiac models.
This application supports vascular endothelial cell assays, myocardial ischemia/reperfusion models, stroke-related oxidative injury, nanozyme efficacy evaluation, preclinical drug delivery studies, and redox-based therapeutic response monitoring.
Technology Comparison Summary
| Application Area | Representative Probe / Strategy | Core Value | Development Focus |
|---|---|---|---|
| Cancer theranostics | ROS-activated fluorescent probes, hydromethidine-related probes | Tumor oxidative stress imaging and therapy monitoring | Activatable fluorescence, NIR emission, tumor microenvironment response |
| Drug development | DCFH-DA, MitoSOX, H₂O₂ probes, GSH/GSSG assays | High-throughput oxidative stress and cytotoxicity evaluation | Plate compatibility, reproducibility, dose-response quantification |
| Neurodegenerative disease | MitoSOX, DCFH-DA, two-photon ROS probes | Mitochondrial oxidative stress and neuroprotection evaluation | Brain/tissue imaging, low background, mitochondrial targeting |
| Cardiovascular disease | ROS probes combined with nanozyme or drug delivery systems | Therapeutic efficacy and oxidative injury assessment | Endothelial models, ischemia/reperfusion models, in vivo compatibility |
Our Advantages
- Integrated ROS probe chemistry and biological validation: We combine molecular design, synthesis, photophysical characterization, selectivity testing, mitochondrial localization validation, and biological assay optimization to generate ROS/redox probes that are chemically responsive and biologically meaningful.
- Mitochondria-focused redox expertise: Our platform supports mitochondria-targeted ROS and redox probe engineering for oxidative phosphorylation stress, mitochondrial dysfunction, apoptosis, ferroptosis, metabolic injury, and drug-induced mitochondrial toxicity.
- Broad analyte and readout coverage: We support H₂O₂, superoxide, GSH/GSSG ratio, total ROS, mitochondrial ROS, and customized redox-responsive probes with turn-on, ratiometric, NIR, two-photon, dual-channel, and high-throughput assay formats.
- Application-oriented assay development: Probe performance can be tailored for live-cell imaging, tissue imaging, high-content screening, flow cytometry, plate-reader assays, zebrafish imaging, preclinical disease models, and nanomedicine evaluation.
- Multi-parameter mitochondrial function profiling: ROS/redox probe assays can be integrated with mitochondrial membrane potential, ATP, calcium, apoptosis, cell viability, mitochondrial morphology, H₂O₂, superoxide, and GSH/GSSG analysis to build a complete mitochondrial oxidative stress profile.
Contact Us
Develop sensitive, selective, and application-specific ROS and redox probes with Protheragen's ROS & Redox Probe Development Service. Contact us with your target analyte, biological model, preferred fluorescence readout, mitochondrial localization requirement, detection platform, and research objective. Our team will recommend a tailored probe development strategy for mitochondrial ROS imaging, oxidative stress analysis, redox biology, cancer research, drug screening, neurodegenerative disease studies, cardiovascular disease models, and translational assay development.
Reference
1. Herb, M., & Schramm, M. (2021). Functions of ROS in Macrophages and Antimicrobial Immunity. Antioxidants (Basel, Switzerland), 10(2), 313.
